J Hepatol

Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance.

Lee S, Arefaine B, Begum N, ..., Shoaie S, Patel VC

J Hepatol 82 (4) 622-633 [2025-04-00; online 2024-10-22]

Adil Mardinoglu Saeed Shoaie SciLifeLab Fellow

Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiers.

Baselli G, Romeo S, Valenti L

J Hepatol 77 (5) 1459-1461 [2022-11-00; online 2022-08-17]

NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis.

Huang B, Lyu Z, Qian Q, ..., You Z, Ma X

J Hepatol 77 (5) 1311-1324 [2022-11-00; online 2022-06-23]

Rare ATG7 genetic variants predispose patients to severe fatty liver disease.

Baselli GA, Jamialahmadi O, Pelusi S, ..., Valenti LV, EPIDEMIC Study Investigators

J Hepatol 77 (3) 596-606 [2022-09-00; online 2022-04-09]

Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages.

Buonomo EL, Mei S, Guinn SR, ..., Kharchenko PV, Sharpe AH

J Hepatol 76 (5) 1127-1137 [2022-05-00; online 2022-01-21]

Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.

Patel VC, Lee S, McPhail MJW, ..., Shoaie S, Shawcross DL

J Hepatol 76 (2) 332-342 [2022-02-00; online 2021-09-24]

Saeed Shoaie SciLifeLab Fellow

Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.

Wilman HR, Parisinos CA, Atabaki-Pasdar N, ..., Banerjee R, Yaghootkar H

J Hepatol 71 (3) 594-602 [2019-09-00; online 2019-06-19]